Healthcare / Medical Care FacilitiesASX
$0.60
-0.04 (-6.25%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $70.5M · quality 61.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$437M
P/E
3000.0x
↑EV/EBITDA
23.0x
↑ROE
0.0%
↓Gross Margin
100.0%
↑Debt/Equity
0.45
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+2.6%
FCF CAGR
+116.0%
FCF margin
56.7%
FCF / Net income
1273.73x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $267.1M · net income $119000.0 · FCF $151.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $267.1M | $267.1M | $260.6M | $265.5M | $247.2M |
| Net Income | $119000.00 | $119000.00 | $30.4M | $31.5M | $15.4M |
| EBITDA | $41.1M | $41.1M | $68.1M | $63.4M | $43.8M |
| EPS | 0.00 | 0.00 | 0.04 | 0.04 | 0.02 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -5.7% | -5.7% | -8.0% | -3.3% | -0.2% |
| Net Margin | 0.0% | 0.0% | 11.7% | 11.9% | 6.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.45 | 0.45 | 0.58 | 0.63 | 0.58 |
| Current Ratio | 0.12 | 0.12 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $151.6M | $151.6M | $70.5M | $33.4M | $15.0M |
| Returns | |||||
| ROE | 0.0% | 0.0% | 2.8% | 3.1% | 1.6% |
| Valuation | |||||
| P/E | 3000.00 | 3000.00 | 13.69 | 13.30 | 31.36 |
| EV/EBITDA | 22.98 | 22.98 | 15.39 | 16.85 | 23.85 |
| P/B | 0.37 | 0.37 | 0.38 | 0.41 | 0.51 |
| Growth & Yield | |||||
| Revenue Growth | 2.5% | 2.5% | -1.8% | 7.4% | — |
| EPS Growth | -99.5% | -99.5% | -4.5% | 100.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
543.3%
EPS terminal req.
$0.05
Spread vs growth
-642.8%
5Y implied EPS CAGR
217.4%
EPS terminal req.
$0.06
Spread vs growth
-316.9%
10Y implied EPS CAGR
86.9%
EPS terminal req.
$0.10
Spread vs growth
-186.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+3.4%
Start / end P/E
13.8x → 3000.0x
EPS bridge
0.04 → 0.00
Residual
-21521.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.